[ad_1]
Stifel Nicolaus increased their target price on shares of Travere Therapeutics from $20.00 to $25.00 and gave the stock a “hold” rating in a report on Friday.
[ad_2]
Source link
[ad_1] Walmart, Home Depot, Lowe’s Companies, Target, Wayfair, Allegion, and Fifth Third Bancorp are the seven Home Improvement stocks to…
[ad_1] Lennar Corporation (NYSE:LEN – Free Report) – Stock analysts at Wedbush cut their Q4 2025 earnings estimates for shares…
[ad_1] Red Robin Gourmet Burgers (NASDAQ:RRGB) will be releasing its Q2 2025 earnings after the market closes on Wednesday, August…